Docetaxel in Non Small Cell Lung Cancer (NSCLC)

Clinical trial NCT00263016 · TERMINATED

Trial details

NCT number: NCT00263016
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2005-05-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.